These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 29634375)
1. Analgesic Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections: A Randomized Crossover Study. Makri OE; Tsapardoni FN; Plotas P; Aretha D; Georgakopoulos CD Curr Eye Res; 2018 Aug; 43(8):1061-1064. PubMed ID: 29634375 [TBL] [Abstract][Full Text] [Related]
2. Analgesic Effect of a Single Drop of Nepafenac 0.3% on Pain Associated with Intravitreal Injections: A Randomized Clinical Trial. Georgakopoulos CD; Plotas P; Kagkelaris K; Tsapardoni F; Makri OE J Ocul Pharmacol Ther; 2019 Apr; 35(3):168-173. PubMed ID: 30688558 [TBL] [Abstract][Full Text] [Related]
3. Diclofenac for pain associated with intravitreal injections: a prospective, randomized, placebo-controlled study. Makri OE; Tsapardoni FN; Pagoulatos DD; Pharmakakis N; Georgakopoulos CD Clin Exp Ophthalmol; 2017 Dec; 45(9):867-874. PubMed ID: 28508561 [TBL] [Abstract][Full Text] [Related]
4. Pain Control after Intravitreal Injection Using Topical Nepafenac 0.3% or Pressure Patching: A Randomized, Placebo-Controlled Trial. Kaplan RI; Drinkwater OJ; Lee RH; Chod RB; Barash A; Giovinazzo JV; Gologorsky D; Jansen ME; Rosen RB; Gentile RC Ophthalmol Retina; 2019 Oct; 3(10):860-866. PubMed ID: 31221565 [TBL] [Abstract][Full Text] [Related]
5. EFFECT OF BROMFENAC ON PAIN RELATED TO INTRAVITREAL INJECTIONS: A Randomized Crossover Study. Georgakopoulos CD; Tsapardoni F; Makri OE Retina; 2017 Feb; 37(2):388-395. PubMed ID: 27442130 [TBL] [Abstract][Full Text] [Related]
7. 0.1% Nepafenac reduces pain and increases patient comfort during cataract surgery. Oğurel T; Oğurel R; Onaran Z; Örnek K Cont Lens Anterior Eye; 2018 Oct; 41(5):448-451. PubMed ID: 29807771 [TBL] [Abstract][Full Text] [Related]
8. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation. Trattler W; McDonald M Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the analgesic efficacy and safety of nepafenac ophthalmic suspension compared with diclofenac ophthalmic solution for ocular pain and photophobia after excimer laser surgery: a phase II, randomized, double-masked trial. Colin J; Paquette B Clin Ther; 2006 Apr; 28(4):527-36. PubMed ID: 16750464 [TBL] [Abstract][Full Text] [Related]
10. Comparison of the Tolerability of Diclofenac and Nepafenac. Achiron A; Karmona L; Mimouni M; Gershoni A; Dzhanov Y; Gur Z; Burgansky Z J Ocul Pharmacol Ther; 2016 Nov; 32(9):601-605. PubMed ID: 27513223 [TBL] [Abstract][Full Text] [Related]
11. COMPARISON OF THE EFFECTS OF EIGHT DIFFERENT TOPICAL NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ON REDUCING INTRAVITREAL INJECTION-INDUCED PAIN. SakallioĞlu AK; Kaya S; Garİp R; Güçlü H Retina; 2024 Jul; 44(7):1196-1202. PubMed ID: 38437826 [TBL] [Abstract][Full Text] [Related]
12. Effects of topical nepafenac on corneal epithelial healing time and postoperative pain after PRK: a bilateral, prospective, randomized, masked trial. Caldwell M; Reilly C J Refract Surg; 2008 Apr; 24(4):377-82. PubMed ID: 18500088 [TBL] [Abstract][Full Text] [Related]
13. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery. Miyake K; Ota I; Miyake G; Numaga J J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758 [TBL] [Abstract][Full Text] [Related]
14. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976 [TBL] [Abstract][Full Text] [Related]
15. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial. Duong HV; Westfield KC; Chalkley TH J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399 [TBL] [Abstract][Full Text] [Related]
16. Effect of nepafenac eye drops on pain associated with pterygium surgery. Ozcimen M; Sakarya Y; Goktas S; Sakarya R; Yener HI; Bukus A; Demir LS Eye Contact Lens; 2015 May; 41(3):187-9. PubMed ID: 25603438 [TBL] [Abstract][Full Text] [Related]
17. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery. Lane SS; Modi SS; Lehmann RP; Holland EJ J Cataract Refract Surg; 2007 Jan; 33(1):53-8. PubMed ID: 17189793 [TBL] [Abstract][Full Text] [Related]
18. Nepafenac 0.3% after Cataract Surgery in Patients with Diabetic Retinopathy: Results of 2 Randomized Phase 3 Studies. Singh RP; Lehmann R; Martel J; Jong K; Pollack A; Tsorbatzoglou A; Staurenghi G; Cervantes-Coste Cervantes G; Alpern L; Modi S; Svoboda L; Adewale A; Jaffe GJ Ophthalmology; 2017 Jun; 124(6):776-785. PubMed ID: 28268098 [TBL] [Abstract][Full Text] [Related]
19. Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery. Maxwell WA; Reiser HJ; Stewart RH; Cavanagh HD; Walters TR; Sager DP; Meuse PA J Ocul Pharmacol Ther; 2008 Dec; 24(6):593-9. PubMed ID: 19040348 [TBL] [Abstract][Full Text] [Related]
20. Role of topical nepafenac in prevention and treatment of macular edema after vitreoretinal surgery. Naithani P; Puranik S; Vashisht N; Khanduja S; Kumar S; Garg S Retina; 2012 Feb; 32(2):250-5. PubMed ID: 21926942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]